In melanoma, NEAT1 binds to BRD4 through the BET domain, blocking WDR5 in a non active form, thereby mediating inhibitory effects on downstream target genes of BRD4 [34]; (2) Mediating epigenetic modification. Here, BRD4 is linked to melanoma.